Newsroom

The research labeled “Investigational Use” was conducted using AliveCor devices in an investigational manner and explore potential future devices and configurations. The devices and configurations used in this research are not commercially available today. AliveCor may make these available in the future after pursuing the appropriate regulatory process. CAUTION: The devices used in the research labeled “Investigational Use” are for investigational use. Restricted by federal (US) law for investigational use only. Click here to gain access to the Investigational Use studies.

Partner with AliveCor

Learn more about our data integration solutions.

Newsroom

Awards

Digital Health Awards Spring 2024

Inc. 2023 Best in Business Honoree

Fast Company's World Changing Ideas Award 2023

Medtech Breakthrough Awards for Best New Technology Solution 2023

Fierce Healthcare Innovation Awards 2022

Digital Health Awards Spring 2022

Most Recent

Former Lions and Wales Rugby Captain Alun Wyn Jones partners with AliveCor to launch ‘Let’s Talk Rhythm’ campaign to raise awareness of atrial fibrillation

AliveCor’s AI-backed ECG Offerings Featured in New Film Series on Innovative Technologies Presented by the Consumer Technology Association

AliveCor Announces the ITC's Limited Exclusion Order Against Apple Clears Presidential Review

FDA Clears Personal ECG Device for Measurement of QTc Interval, a Critical Marker for Patient Safety

AliveCor Acquires CardioLabs and Sets the Stage for the Launch of Advanced Ambulatory Monitoring Services

Apple Abused Market Power in Cardio Device Market, Suit Alleges

Three New Studies Confirm Clinical Utility of AliveCor's KardiaMobile Device and AI Algorithms

AliveCor Appoints Dr. Jacqueline Shreibati, Chief Medical Officer

AliveCor's Mobile ECG Technology Could Enable More Rapid Diagnosis and Treatment of Heart Attacks

AliveCor Named No.1 Artificial Intelligence Company in Fast Company’s 2018 Most Innovative Companies Ranking

AliveCor Granted Patent for Proactive Notification of Possible Heart Arrhythmias

AliveCor Announces Results of SEARCH-AF Trial

AliveCor Supports UCSF’s Online Health eHeart Study

AliveCor Unveils Versatile Mobile Heart Monitor

AliveCor Launches New Feature to Enhance Visual Quality of ECG

AliveCor Expands Mobile ECG Device Offering to United Kingdom & Ireland

U.K. Hospitals to Use New AliveCor Heart Monitor During Heart Rhythm

AliveCor Expands Mobile ECG Device Offering to Include iPhone 5

AliveCor Mobile ECG Device for Heart Rhythm Monitoring Now Available by Prescription

AliveCor’s Heart Monitor for iPhone Receives FDA Clearance

Investigational Use